Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Fractyl Health (GUTS) Equity Average (2023 - 2025)

Fractyl Health's Equity Average history spans 3 years, with the latest figure at $3.1 million for Q4 2025.

  • For the quarter ending Q4 2025, Equity Average fell 92.02% year-over-year to $3.1 million, compared with a TTM value of $3.1 million through Dec 2025, down 92.02%, and an annual FY2025 reading of $18.9 million, up 112.77% over the prior year.
  • Equity Average for Q4 2025 was $3.1 million at Fractyl Health, up from -$10.7 million in the prior quarter.
  • The five-year high for Equity Average was $77.5 million in Q2 2024, with the low at -$316.1 million in Q4 2023.
  • Average Equity Average over 3 years is -$75.7 million, with a median of -$5.9 million recorded in 2025.
  • Year-over-year, Equity Average skyrocketed 127.87% in 2024 and then plummeted 117.67% in 2025.
  • Tracing GUTS's Equity Average over 3 years: stood at -$316.1 million in 2023, then surged by 112.46% to $39.4 million in 2024, then plummeted by 92.02% to $3.1 million in 2025.
  • Per Business Quant, the three most recent readings for GUTS's Equity Average are $3.1 million (Q4 2025), -$10.7 million (Q3 2025), and -$5.9 million (Q2 2025).